Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol.


Journal

BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806

Informations de publication

Date de publication:
09 2023
Historique:
received: 21 06 2023
accepted: 31 08 2023
medline: 22 9 2023
pubmed: 21 9 2023
entrez: 20 9 2023
Statut: ppublish

Résumé

The success of keratoplasty strongly depends on the health status of the transplanted endothelial cells. Donor corneal tissues are routinely screened for endothelial damage before shipment; however, surgical teams have currently no means of assessing the overall viability of corneal endothelium immediately prior to transplantation. The aim of this study is to validate a preoperative method of evaluating the endothelial health of donor corneal tissues, to assess the proportion of tissues deemed suitable for transplantation by the surgeons and to prospectively record the clinical outcomes of a cohort of patients undergoing keratoplasty in relation to preoperatively defined endothelial viability. In this multicentre cohort study, consecutive patients undergoing keratoplasty (perforating keratoplasty, Descemet stripping automated endothelial keratoplasty (DSAEK), ultra-thin DSAEK (UT-DSAEK) or Descemet membrane endothelial keratoplasty) will be enrolled and followed-up for 1 year. Before transplantation, the endothelial viability of the donor corneal tissue will be evaluated preoperatively through trypan blue staining and custom image analysis to estimate the overall percentage of trypan blue-positive areas (TBPAs), a proxy of endothelial damage. Functional and structural outcomes at the end of the follow-up will be correlated with preoperatively assessed TBPA values. The protocol will be reviewed by the ethical committees of participating centres, with the sponsor centre issuing the final definitive approval. The results will be disseminated on ClinicalTrials.gov, at national and international conferences, by partner patient groups and in open access, peer-reviewed journals. NCT05847387.

Identifiants

pubmed: 37730252
pii: bmjophth-2023-001361
doi: 10.1136/bmjophth-2023-001361
pmc: PMC10510883
pii:
doi:

Substances chimiques

Trypan Blue I2ZWO3LS3M

Banques de données

ClinicalTrials.gov
['NCT05847387']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: YZ, SK and VR are editors of BMJ Open Ophthalmology.

Références

Int J Biostat. 2016 Nov 1;12(2):
pubmed: 27838682
Transplantation. 2008 Dec 27;86(12):1720-4
pubmed: 19104411
Ophthalmology. 2013 Dec;120(12):2428-2435
pubmed: 24246826
Am J Ophthalmol. 2021 Apr;224:254-266
pubmed: 33129808
JAMA Ophthalmol. 2015 Nov;133(11):1277-85
pubmed: 26355238
Invest Ophthalmol Vis Sci. 2014 Nov 25;55(12):8409-15
pubmed: 25425307
JAMA Ophthalmol. 2015 Nov;133(11):1285-6
pubmed: 26356492
JAMA Ophthalmol. 2015 Mar;133(3):246-54
pubmed: 25322173
PLoS One. 2017 Sep 13;12(9):e0184375
pubmed: 28902856
Arch Ophthalmol. 2004 May;122(5):736-42
pubmed: 15136322
Br J Ophthalmol. 2022 Feb;106(2):177-183
pubmed: 33127828
Br J Ophthalmol. 2016 Apr;100(4):572-8
pubmed: 26740609
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):6018-25
pubmed: 21666243

Auteurs

Matteo Airaldi (M)

Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy.
St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

Yalin Zheng (Y)

Department of Eye and Vision Science, University of Liverpool, Liverpool, UK.

Francesco Aiello (F)

Department of Experimental Medicine, Università degli Studi di Roma Tor Vergata, Roma, Italy.

Björn Bachmann (B)

Department of Ophthalmology, Uniklinik Köln, Koln, Germany.

Lamis Baydoun (L)

Department of Ophthalmology, Universitätsklinikum Münster, Munster, Germany.
ELZA Institute, Dietikon, Zurich, Switzerland.

Sorcha Ní Dhubhghaill (S)

Department of Translational Neurosciences, University Hospital Antwerp, Wilrijk, Belgium.
Department of Ophthalmology, University Hospital of Brussel, Jette, Belgium.

Mor M Dickman (MM)

Eye Clinic, Maastricht UMC+, Maastricht, The Netherlands.
MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, Netherlands.

Stephen B Kaye (SB)

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
Department of Eye and Vision Science, University of Liverpool, Liverpool, UK.

Luigi Fontana (L)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Kunal A Gadhvi (KA)

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

Antonello Moramarco (A)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Marina Rodriguez Calvo de Mora (M)

Hospital Regional Universitario de Málaga, Málaga, Spain.
Qvision, VITHAS Almería, Almería, Spain.
Department of Ophthalmology, VITHAS Málaga, Málaga, Spain.

Carlos Rocha de Lossada (C)

Hospital Regional Universitario de Málaga, Málaga, Spain.
Qvision, VITHAS Almería, Almería, Spain.
Department of Ophthalmology, VITHAS Málaga, Málaga, Spain.
Surgery Department, Ophthalmology Area, University of Seville, Sevilla, Spain.

Vincenzo Scorcia (V)

Department of Medical and Surgical Sciences, Università degli Studi "Magna Græcia" di Catanzaro, Catanzaro, Italy.

Pietro Viola (P)

Ophthalmology Unit, Ospedale San Bortolo di Vicenza, Vicenza, Italy.

Stefano Calza (S)

Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy.

Hannah J Levis (HJ)

Department of Eye and Vision Science, University of Liverpool, Liverpool, UK.

Mohit Parekh (M)

Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.

Alessandro Ruzza (A)

Fondazione Banca degli Occhi del Veneto, Venezia, Italy.

Stefano Ferrari (S)

Fondazione Banca degli Occhi del Veneto, Venezia, Italy.

Diego Ponzin (D)

Fondazione Banca degli Occhi del Veneto, Venezia, Italy.

Francesco Semeraro (F)

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Università degli Studi di Brescia, Brescia, Italy.

Vito Romano (V)

Department of Eye and Vision Science, University of Liverpool, Liverpool, UK vito.romano@gmail.com.
Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Università degli Studi di Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH